Last edition
News about Biotechnology
GSK will acquire RAPT Therapeutics for USD 2.2 billion, adding phase IIb anti-IgE antibody ozureprubart to its pipeline, targeting long-acting protection for patients with severe food allergies.
Biotechnology | 20/01/2026 | By News Bureau
Onyx Scientific Strengthens Solid Form Screening Platform Following 25-Year Milestone
Onyx Scientific, the contract development and manufacturing organisation (CDMO) division of Ipca Laboratories, has announced plans to expand its solid form and material science screening capabilities in 2026, following the celebration of its 25th anniversary at the end of 2025.
Biotechnology | 20/01/2026 | By Darshana
European Commission Approves Sobi's Aspaveli for Rare Kidney Diseases C3G and IC-MPGN
The European Commission has approved Sobi’s Aspaveli for adolescents and adults with rare kidney diseases C3G and IC-MPGN, marking the first approved therapy for these conditions.
Biotechnology | 19/01/2026 | By News Bureau
IDT- Ansa Alliance Brings High-Complexity, Long-Length DNA Synthesis to Global Researchers
Integrated DNA Technologies (IDT), a Danaher company and a global genomics solutions provider, has entered into a strategic collaboration with Ansa Biotechnologies Inc to enhance its synthetic biology portfolio with advanced DNA synthesis capabilities.
Biotechnology | 17/01/2026 | By Darshana
BD Secures FDA 510(k) Clearance for EnCor EnCompass Multi-Modality Breast Biopsy System
BD has received FDA 510(k) clearance for its EnCor EnCompass multi-modality breast biopsy system, designed to improve procedural efficiency, clinician flexibility and early detection and diagnosis of breast disease.
Biotechnology | 17/01/2026 | By News Bureau
Risa Labs Raises USD 11.1M Series A to Scale AI OS for Oncology Care
The funding led by Cencora Ventures and Optum Ventures will accelerate nationwide deployment of Risa’s AI-driven platform to streamline oncology workflows, reduce delays and improve patient access to cancer therapies.
Biotechnology | 14/01/2026 | By News Bureau | 150
Dr Jitendra Singh Inaugurates SAMARTH Skill Centre, iDeA-NA Tech Incubator at DBT-CDFD, Hyderabad
While inaugurating the initiatives, Dr Jitendra Singh, Union Minister of State (Independent Charge), Science & Technology, Earth Sciences, and Minister of State, PMO, Department of Space and Department of Atomic Energy, highlighted India’s transition towards futuristic healthcare, early disease detection, affordability and personalised medicine.
Biotechnology | 12/01/2026 | By News Bureau
Biocon Biologics to Showcase Keytruda and Two New Oncology Biosimilars at JPM 2026
Biocon Biologics, the biosimilars arm of Biocon Ltd, is set to introduce three new oncology biosimilars, including a biosimilar of pembrolizumab (Keytruda), at the J.P. Morgan Healthcare Conference 2026 in San Francisco.
Biotechnology | 07/01/2026 | By Darshana | 120
Lilly in Advanced Talks to Acquire Ventyx Biosciences in Deal Worth Over USD 1 Billion
Eli Lilly & Company is in advanced discussions to acquire Ventyx Biosciences in a deal valued at more than USD 1 billion, according to reports citing people familiar with the matter. The acquisition talks have attracted strong investor interest, with Ventyx shares rising sharply following the news.
Biotechnology | 07/01/2026 | By Darshana | 133
WuXi Biologics, a global contract research, development and manufacturing organisation (CRDMO), has achieved ISO 20400 Sustainable Procurement certification, a globally recognised standard that embeds sustainability principles into procurement practices and promotes transparency, accountability and responsible supply chain management.
Biotechnology | 06/01/2026 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy